|
|
||||||||
Department of Cardiology, KCL, The Rayne Institute, St. Thomas Hospital London SE1 7EH, U.K.; and
* Department of Physiology, University of Maryland School of Medicine, Baltimore, Maryland 21201, USA
1Correspondence: Department of Cardiology, KCL, The Rayne Institute, St. Thomas Hospital, London SE1 7EH, U.K. E-mail: mike.marber{at}kcl.ac.uk
Activation of protein kinase C (PKC) and more recently mitogen-activated
protein kinases (MAPKs) have been associated with the cardioprotective
effect of ischemic preconditioning. We examined the interplay between
these kinases in a characterized model of ischemic preconditioning in
cultured rat neonatal ventricular cardiocytes where ectopic expression
of active PKC-
results in protection. Two members of the MAPK
family, p38 and p42/44, were activated transiently during
preconditioning by brief simulated ischemia/reoxygenation.
Overexpression of active PKC-
, rather than augmenting, completely
abolished this activation. We therefore determined whether a similar
process occurred during lethal prolonged simulated ischemia. In
contrast to ischemia, brief, lethal-simulated ischemia activated only
p38 (2.8±0.45 vs. basal, P<0.01), which was attenuated
by expression of active PKC-
or by preconditioning (0.48±0.1 vs.
ischemia, P<0.01). To determine whether reduced p38
activation was the cause or an effect of protection, we used SB203580,
a p38 inhibitor. SB203580 reduced ischemic injury (CK release
38.0±3.1%, LDH release 77.3±4.0%, and MTT bioreduction 127.1±4.8%
of control, n=20, P<0.05). To determine
whether p38 activation was isoform selective, myocytes were infected
with adenoviruses encoding wild-type p38
or p38ß. Transfected
p38
and ß show differential activation (P<0.001)
during sustained simulated ischemia, with p38
remaining activated
(1.48±0.36 vs. basal) but p38ß deactivated (0.36±0.1 vs. basal,
P<0.01). Prior preconditioning prevented the activation
of p38
(0.65±0.11 vs. ischemia, P<0.05). Moreover,
cells expressing a dominant negative p38
, which prevented ischemic
p38 activation, were resistant to lethal simulated ischemia (CK release
82.9±3.9% and MTT bioreduction 130.2±6.5% of control,
n=8, P<0.05). Thus, inhibition of p38
activation during ischemia reduces injury and may contribute to
preconditioning-induced cardioprotection in this model.Saurin,
A. T., Martin, J. L., Heads, R. J., Foley, C.,
Mockridge, J. W., Wright, M. J., Wang, Y., Marber, M. S.
The role of differential activation of p38-mitogen-activated protein
kinase in preconditioned ventricular myocytes.
Key Words: myocardial ischemia cardioprotection ischemic preconditioning cytoprotection
This article has been cited by other articles:
![]() |
L. Y. Teos, A. Zhao, Z. Alvin, G. G. Laurence, C. Li, and G. E. Haddad Basal and IGF-I-dependent regulation of potassium channels by MAP kinases and PI3-kinase during eccentric cardiac hypertrophy Am J Physiol Heart Circ Physiol, November 1, 2008; 295(5): H1834 - H1845. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Murphy and C. Steenbergen Mechanisms Underlying Acute Protection From Cardiac Ischemia-Reperfusion Injury Physiol Rev, April 1, 2008; 88(2): 581 - 609. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Heidbreder, A. Naumann, K. Tempel, P. Dominiak, and A. Dendorfer Remote vs. ischaemic preconditioning: the differential role of mitogen-activated protein kinase pathways Cardiovasc Res, April 1, 2008; 78(1): 108 - 115. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Jacquet, E. Zarrinpashneh, A. Chavey, A. Ginion, I. Leclerc, B. Viollet, G. A. Rutter, L. Bertrand, and M. S. Marber The relationship between p38 mitogen-activated protein kinase and AMP-activated protein kinase during myocardial ischemia Cardiovasc Res, December 1, 2007; 76(3): 465 - 472. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Clark, R. A. Flavell, M. E. Faircloth, R. J. Davis, R. J. Heads, and M. S. Marber Post-infarction remodeling is independent of mitogen-activated protein kinase kinase 3 (MKK3) Cardiovasc Res, June 1, 2007; 74(3): 466 - 470. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. G. Ossum, T. Wulff, and E. K. Hoffmann Regulation of the mitogen-activated protein kinase p44 ERK activity during anoxia/recovery in rainbow trout hypodermal fibroblasts J. Exp. Biol., May 1, 2006; 209(9): 1765 - 1776. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Khan, S. Varadharaj, L. P. Ganesan, J. C. Shobha, M. U. Naidu, N. L. Parinandi, S. Tridandapani, V. K. Kutala, and P. Kuppusamy C-phycocyanin protects against ischemia-reperfusion injury of heart through involvement of p38 MAPK and ERK signaling Am J Physiol Heart Circ Physiol, May 1, 2006; 290(5): H2136 - H2145. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Hausenloy and D. M. Yellon Survival kinases in ischemic preconditioning and postconditioning Cardiovasc Res, May 1, 2006; 70(2): 240 - 253. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. Kim, A. Pedram, M. Razandi, and E. R. Levin Estrogen Prevents Cardiomyocyte Apoptosis through Inhibition of Reactive Oxygen Species and Differential Regulation of p38 Kinase Isoforms J. Biol. Chem., March 10, 2006; 281(10): 6760 - 6767. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kyoi, H. Otani, S. Matsuhisa, Y. Akita, K. Tatsumi, C. Enoki, H. Fujiwara, H. Imamura, H. Kamihata, and T. Iwasaka Opposing effect of p38 MAP kinase and JNK inhibitors on the development of heart failure in the cardiomyopathic hamster Cardiovasc Res, March 1, 2006; 69(4): 888 - 898. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Okada, H. Otani, Y. Wu, S. Kyoi, C. Enoki, H. Fujiwara, T. Sumida, R. Hattori, and H. Imamura Role of F-actin organization in p38 MAP kinase-mediated apoptosis and necrosis in neonatal rat cardiomyocytes subjected to simulated ischemia and reoxygenation Am J Physiol Heart Circ Physiol, December 1, 2005; 289(6): H2310 - H2318. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. House, K. Branch, G. Newman, T. Doetschman, and J. E. J. Schultz Cardioprotection induced by cardiac-specific overexpression of fibroblast growth factor-2 is mediated by the MAPK cascade Am J Physiol Heart Circ Physiol, November 1, 2005; 289(5): H2167 - H2175. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. P D Wheeler-Jones Cell signalling in the cardiovascular system: an overview Heart, October 1, 2005; 91(10): 1366 - 1374. [Full Text] [PDF] |
||||
![]() |
T. Sumida, H. Otani, S. Kyoi, T. Okada, H. Fujiwara, Y. Nakao, M. Kido, and H. Imamura Temporary blockade of contractility during reperfusion elicits a cardioprotective effect of the p38 MAP kinase inhibitor SB-203580 Am J Physiol Heart Circ Physiol, June 1, 2005; 288(6): H2726 - H2734. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Schulz A new paradigm: cross talk of protein kinases during reperfusion saves life! Am J Physiol Heart Circ Physiol, January 1, 2005; 288(1): H1 - H2. [Full Text] [PDF] |
||||
![]() |
M. Yada, A. Shimamoto, C. R. Hampton, A. J. Chong, H. Takayama, C. L. Rothnie, D. J. Spring, H. Shimpo, I. Yada, T. H. Pohlman, et al. FR167653 diminishes infarct size in a murine model of myocardial ischemia-reperfusion injury J. Thorac. Cardiovasc. Surg., October 1, 2004; 128(4): 588 - 594. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Porras, S. Zuluaga, E. Black, A. Valladares, A. M. Alvarez, C. Ambrosino, M. Benito, and A. R. Nebreda p38{alpha} Mitogen-activated Protein Kinase Sensitizes Cells to Apoptosis Induced by Different Stimuli Mol. Biol. Cell, February 1, 2004; 15(2): 922 - 933. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Schulz, S. Aker, S. Belosjorow, I. Konietzka, U. Rauen, and G. Heusch Stress kinase phosphorylation is increased in pacing-induced heart failure in rabbits Am J Physiol Heart Circ Physiol, November 1, 2003; 285(5): H2084 - H2090. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. YELLON and J. M. DOWNEY Preconditioning the Myocardium: From Cellular Physiology to Clinical Cardiology Physiol Rev, October 1, 2003; 83(4): 1113 - 1151. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tanno, R. Bassi, D. A. Gorog, A. T. Saurin, J. Jiang, R. J. Heads, J. L. Martin, R. J. Davis, R. A. Flavell, and M. S. Marber Diverse Mechanisms of Myocardial p38 Mitogen-Activated Protein Kinase Activation: Evidence for MKK-Independent Activation by a TAB1-Associated Mechanism Contributing to Injury During Myocardial Ischemia Circ. Res., August 8, 2003; 93(3): 254 - 261. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Qin, J. Shite, and C.-s. Liang Antioxidants attenuate myocyte apoptosis and improve cardiac function in CHF: association with changes in MAPK pathways Am J Physiol Heart Circ Physiol, July 11, 2003; 285(2): H822 - H832. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Ping A new chapter in cardiac PKC signaling studies: searching for isoform-specific molecular targets. Focus on: "Isoenzyme-selective regulation of SERCA2 gene expression by protein kinase C in neonatal rat ventricular myocytes" Am J Physiol Cell Physiol, July 1, 2003; 285(1): C19 - C21. [Full Text] [PDF] |
||||
![]() |
C. Zhang, D. M. Rosenbaum, A. R. Shaikh, Q. Li, P. S. Rosenbaum, D. J. Pelham, and S. Roth Ischemic Preconditioning Attenuates Apoptotic Cell Death in the Rat Retina Invest. Ophthalmol. Vis. Sci., September 1, 2002; 43(9): 3059 - 3066. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Seta, Z. Spicer, Y. Yuan, G. Lu, and D. E. Millhorn Responding to Hypoxia: Lessons From a Model Cell Line Sci. Signal., August 20, 2002; 2002(146): re11 - re11. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. T Saurin, D. J Pennington, N. J.H Raat, D. S Latchman, M. J Owen, and M. S Marber Targeted disruption of the protein kinase C epsilon gene abolishes the infarct size reduction that follows ischaemic preconditioning of isolated buffer-perfused mouse hearts Cardiovasc Res, August 15, 2002; 55(3): 672 - 680. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Yue, Q. Qin, M. V Cohen, J. M Downey, and S. D Critz The relative order of mKATP channels, free radicals and p38 MAPK in preconditioning's protective pathway in rat heart Cardiovasc Res, August 15, 2002; 55(3): 681 - 689. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Schulz, S. Belosjorow, P. Gres, J. Jansen, M. C Michel, and G. Heusch p38 MAP kinase is a mediator of ischemic preconditioning in pigs Cardiovasc Res, August 15, 2002; 55(3): 690 - 700. [Abstract] [Full Text] [PDF] |
||||
![]() |
B.G. PETRICH, P. LIAO, and Y. WANG Using a Gene-switch Transgenic Approach to Dissect Distinct Roles of MAP Kinases in Heart Failure Cold Spring Harb Symp Quant Biol, January 1, 2002; 67(0): 429 - 438. [Abstract] [PDF] |
||||
![]() |
R. Schulz, M. V Cohen, M. Behrends, J. M Downey, and G. Heusch Signal transduction of ischemic preconditioning Cardiovasc Res, November 1, 2001; 52(2): 181 - 198. [Full Text] [PDF] |
||||
![]() |
R. M. Fryer, H. H. Patel, A. K. Hsu, and G. J. Gross Stress-activated protein kinase phosphorylation during cardioprotection in the ischemic myocardium Am J Physiol Heart Circ Physiol, September 1, 2001; 281(3): H1184 - H1192. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Yue, M. Krenz, M. V. Cohen, J. M. Downey, and S. D. Critz Menadione mimics the infarct-limiting effect of preconditioning in isolated rat hearts Am J Physiol Heart Circ Physiol, August 1, 2001; 281(2): H590 - H595. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. K Brar, A. Stephanou, Z. Liao, R. M O'Leary, D. Pennica, D. M Yellon, and D. S Latchman Cardiotrophin-1 can protect cardiac myocytes from injury when added both prior to simulated ischaemia and at reoxygenation Cardiovasc Res, August 1, 2001; 51(2): 265 - 274. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Park, A. Chen, and J. V. Bonventre Prevention of Kidney Ischemia/Reperfusion-induced Functional Injury and JNK, p38, and MAPK Kinase Activation by Remote Ischemic Pretreatment J. Biol. Chem., April 6, 2001; 276(15): 11870 - 11876. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Martin, M. Avkiran, R. A. Quinlan, P. Cohen, and M. S. Marber Antiischemic Effects of SB203580 Are Mediated Through the Inhibition of p38{alpha} Mitogen-Activated Protein Kinase: Evidence From Ectopic Expression of an Inhibition-Resistant Kinase Circ. Res., October 26, 2001; 89(9): 750 - 752. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Heidkamp, A. L. Bayer, J. L. Martin, and A. M. Samarel Differential Activation of Mitogen-Activated Protein Kinase Cascades and Apoptosis by Protein Kinase C {epsilon} and {delta} in Neonatal Rat Ventricular Myocytes Circ. Res., November 9, 2001; 89(10): 882 - 890. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |